This was confirmed through a study by Schubart C. et al., which compared detection results of 205 consecutive NSCLC cases with MET alterations, using either an amplicon-based, 15-gene NGS panel, or the standard FISH method. The gene discussed is MET; the disease is non-small cell lung carcinoma.